Clinical Case Report: LECT2-Associated Adrenal Amyloidosis

ABSTRACT Objective: Leukocyte chemotactic factor-2 (LECT2)- associated amyloidosis is a newly discovered cause of amyloid and has thus far been reported to involve only the kidneys. We report a case of amyloidosis of the adrenal gland, along with involvement of the kidney, in a patient with primary aldosteronism. Methods: Tissue samples from the patient were analyzed using tandem mass spectrometry to identify the amyloid protein, followed by Western blot. DNA sequencing was performed to evaluate genetic polymorphisms. Results: Tandem mass spectrometry identified the amyloid protein as LECT2, and its identity was confirmed by Western blot. Genetic analysis revealed the patient to be homozygous for a genetic polymorphism of the LECT2 gene. Serum levels of LECT2 were undetectable, and no mutations were found in the CTNNB1, KCNJ5, ATP1A1, or ATP2B3 genes. Conclusion: This case appears to be the first published report to describe LECT 2-associated amyloidosis both outside of the kidney and within the adrenal g...

[1]  J. Bertherat,et al.  WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. , 2014, Human molecular genetics.

[2]  Tetsurou Yamamoto,et al.  Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry. , 2013, The Journal of clinical endocrinology and metabolism.

[3]  A. Yergey,et al.  Quantitative Proteomic Analysis of Niemann-Pick Disease, Type C1 Cerebellum Identifies Protein Biomarkers and Provides Pathological Insight , 2012, PloS one.

[4]  V. Baud,et al.  Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. , 2012, The Journal of clinical investigation.

[5]  P. Tarugi,et al.  Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. , 2011, Advances in clinical chemistry.

[6]  D. Holanda,et al.  Atypical presentation of atypical amyloid. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  D. Benson,et al.  Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  A. Solomon,et al.  Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. , 2010, Kidney international.

[9]  W. Young,et al.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[10]  K. Scott,et al.  Leukocyte chemotactic factor 2: A novel renal amyloid protein. , 2008, Kidney international.

[11]  A. Goette,et al.  Prevalence and pathology of amyloid in atherosclerotic arteries. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[12]  J. Bertherat,et al.  Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. , 2005, Cancer research.

[13]  K. Hatakeyama,et al.  Serum LECT2 level as a prognostic indicator in acute liver failure. , 2004, Transplantation proceedings.

[14]  Kazuo Suzuki,et al.  Identification of the leukocyte cell‐derived chemotaxin 2 as a direct target gene of β‐catenin in the liver , 2004, Hepatology.

[15]  Hans Clevers,et al.  Caught up in a Wnt storm: Wnt signaling in cancer. , 2003, Biochimica et biophysica acta.

[16]  C. Fenoglio-Preiser,et al.  beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. , 2002, Cancer research.

[17]  M. Buendia,et al.  Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Suzuki,et al.  Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2. , 1996, Immunology letters.

[19]  D. Rader,et al.  In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. , 1992, Journal of lipid research.

[20]  R. Schrier,et al.  Role of aldosterone in the sodium retention of patients with nephrotic syndrome. , 1990, American journal of nephrology.

[21]  J. Liepnieks,et al.  Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. , 1988, Biochemical and biophysical research communications.